Specific delivery of αCD38‐tLNPs to BM‐residing and disseminated MM cells and the improvement in therapeutic outcome of MM‐bearing mice treated with αCD38‐tLNPs‐siRNA‐CKAP5 are shown. Here, CKAP5 is linked to Miyoshi myopathy.